Literature DB >> 15481316

Relationship between fecal calprotectin, intestinal inflammation, and peripheral blood neutrophils in patients with active ulcerative colitis.

Hiroyuki Hanai1, Ken Takeuchi, Takayuki Iida, Nobuhito Kashiwagi, Abby R Saniabadi, Isao Matsushita, Yoshihiko Sato, Naoki Kasuga, Toshihiro Nakamura.   

Abstract

Active ulcerative colitis (UC) is associated with elevated granulocytes and monocytes/macrophages (GM) which show activation behavior and increased survival time. Further, fecal calprotectin (a stable neutrophil protein) level parallels intestinal inflammation and can predict UC relapse. Since GM are major sources of inflammatory cytokines and chemokines, they are suspected to have roles in the initiation and perpetuation of UC. Our objective was to investigated relationships between peripheral blood (PB) neutrophils, calprotectin, and UC disease activity. Full PB and calprotectin were determined in 69 healthy controls and 31 patients with UC, then 7 randomly selected patients received GM adsorptive apheresis (GMA) with Adacolumn, 10 sessions of 60-min duration each. Patients with UC had higher neutrophil counts (P < 0.001), but lower lymphocyte counts (P < 0.001) compared with controls. Further, fecal calprotectin levels showed a correlation with UC clinical activity index (CAI; P < 0.001) and mucosal inflammation (P < 0.001). Following GMA, there were falls in neutrophils (P < 0.02), CAI (P < 0.02) and calprotectin (P < 0.02). In conclusion, GM appear to contribute to intestinal inflammation and UC activity and reduction of these cells by GMA should benefit patients with active UC. Further, the correlations among calprotectin, UC activities, and PB neutrophils should serve as the basis for preemptive actions to control this disease.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15481316     DOI: 10.1023/b:ddas.0000042243.47279.87

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  22 in total

Review 1.  Selective bloodletting for severe ulcerative colitis.

Authors:  P Premehand; K Takeuchi; I Bjarnason
Journal:  Scand J Gastroenterol       Date:  2004-05       Impact factor: 2.423

2.  The value of rectal biopsy in the diagnosis of ulcerative colitis.

Authors:  S G MATTS
Journal:  Q J Med       Date:  1961-10

3.  Opposing effects of glucocorticoids on the rate of apoptosis in neutrophilic and eosinophilic granulocytes.

Authors:  L C Meagher; J M Cousin; J R Seckl; C Haslett
Journal:  J Immunol       Date:  1996-06-01       Impact factor: 5.422

4.  Neutrophil apoptosis is delayed in patients with inflammatory bowel disease.

Authors:  A E Brannigan; P R O'Connell; H Hurley; A O'Neill; H R Brady; J M Fitzpatrick; R W Watson
Journal:  Shock       Date:  2000-05       Impact factor: 3.454

Review 5.  Intestinal permeability: an overview.

Authors:  I Bjarnason; A MacPherson; D Hollander
Journal:  Gastroenterology       Date:  1995-05       Impact factor: 22.682

6.  Surrogate markers of intestinal inflammation are predictive of relapse in patients with inflammatory bowel disease.

Authors:  J A Tibble; G Sigthorsson; S Bridger; M K Fagerhol; I Bjarnason
Journal:  Gastroenterology       Date:  2000-07       Impact factor: 22.682

7.  Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial.

Authors:  D Rachmilewitz
Journal:  BMJ       Date:  1989-01-14

8.  Correlation between faecal excretion of indium-111-labelled granulocytes and calprotectin, a granulocyte marker protein, in patients with inflammatory bowel disease.

Authors:  A G Røseth; P N Schmidt; M K Fagerhol
Journal:  Scand J Gastroenterol       Date:  1999-01       Impact factor: 2.423

9.  Studies on the mechanisms of leukocyte adhesion to cellulose acetate beads: an in vitro model to assess the efficacy of cellulose acetate carrier-based granulocyte and monocyte adsorptive apheresis.

Authors:  Katsuya Hiraishi; Yuji Takeda; Noriyuki Shiobara; Hiromu Shibusawa; Fumie Jimma; Nobuhito Kashiwagi; Abby R Saniabadi; Masakazu Adachi
Journal:  Ther Apher Dial       Date:  2003-06       Impact factor: 1.762

10.  Enhanced synthesis of leukotriene B4 by colonic mucosa in inflammatory bowel disease.

Authors:  P Sharon; W F Stenson
Journal:  Gastroenterology       Date:  1984-03       Impact factor: 22.682

View more
  44 in total

Review 1.  Molecular fingerprints of neutrophil-dependent oxidative stress in inflammatory bowel disease.

Authors:  Yuji Naito; Tomohisa Takagi; Toshikazu Yoshikawa
Journal:  J Gastroenterol       Date:  2007-10-15       Impact factor: 7.527

Review 2.  Clinical implications of mucosal healing for the management of IBD.

Authors:  Guillaume Pineton de Chambrun; Laurent Peyrin-Biroulet; Marc Lémann; Jean-Frédéric Colombel
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2009-12-01       Impact factor: 46.802

Review 3.  Immunological Mechanisms of Adsorptive Cytapheresis in Inflammatory Bowel Disease.

Authors:  Esteban Sáez-González; Inés Moret; Diego Alvarez-Sotomayor; Francia Carolina Díaz-Jaime; Elena Cerrillo; Marisa Iborra; Pilar Nos; Belén Beltrán
Journal:  Dig Dis Sci       Date:  2017-04-21       Impact factor: 3.199

4.  Utility of faecal calprotectin analysis in adult inflammatory bowel disease.

Authors:  Lyn A Smith; Daniel R Gaya
Journal:  World J Gastroenterol       Date:  2012-12-14       Impact factor: 5.742

Review 5.  Gleaning Insights from Fecal Microbiota Transplantation and Probiotic Studies for the Rational Design of Combination Microbial Therapies.

Authors:  Lauren E Hudson; Sarah E Anderson; Anita H Corbett; Tracey J Lamb
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

6.  Calprotectin and lactoferrin in the assessment of intestinal inflammation and organic disease.

Authors:  Renata D'Incà; Elisabetta Dal Pont; Vincenza Di Leo; Antonio Ferronato; Walter Fries; Maria Grazia Vettorato; Diego Martines; Giacomo Carlo Sturniolo
Journal:  Int J Colorectal Dis       Date:  2006-07-13       Impact factor: 2.571

7.  Neutrophil-related immunoinflammatory disturbance in steroid-overdosed ulcerative colitis patients.

Authors:  Shigeyuki Yoshiyama; Chikao Miki; Yoshiki Okita; Toshimitsu Araki; Keiichi Uchida; Masato Kusunoki
Journal:  J Gastroenterol       Date:  2008-10-29       Impact factor: 7.527

8.  Adsorptive depletion of alpha4 integrin(hi)- and CX3CR1hi-expressing proinflammatory monocytes in patients with ulcerative colitis.

Authors:  Shin-ichiro Takeda; Toru Sato; Tatsuro Katsuno; Tomoo Nakagawa; Yoshiko Noguchi; Osamu Yokosuka; Yasushi Saito
Journal:  Dig Dis Sci       Date:  2009-11-12       Impact factor: 3.199

9.  Inflammatory bowel disease activity assessed by fecal calprotectin and lactoferrin: correlation with laboratory parameters, clinical, endoscopic and histological indexes.

Authors:  Andrea Vieira; Chia Bin Fang; Ernani Geraldo Rolim; Wilmar Artur Klug; Flávio Steinwurz; Lucio Giovanni Battista Rossini; Paulo Azevedo Candelária
Journal:  BMC Res Notes       Date:  2009-10-29

10.  Fecal calprotectin correlated with endoscopic remission for Asian inflammatory bowel disease patients.

Authors:  Wei-Chen Lin; Jau-Min Wong; Chien-Chih Tung; Ching-Pin Lin; Jen-Wei Chou; Horng-Yuan Wang; Ming-Jium Shieh; Chin-Hao Chang; Heng-Hsiu Liu; Shu-Chen Wei
Journal:  World J Gastroenterol       Date:  2015-12-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.